smoothlax
NDC 0363-1323, Polyethylene Glycol 3350, powder, for solution, from Walgreen Company.
- Product NDC
- 0363-1323
- Status
- Listed
- Labeler
- Walgreen Company
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA090685
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0363-1323 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POLYETHYLENE GLYCOL 335017 g/17g
Pharmacologic classes
Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0363-1323-02 | 00363132302 | 238 g in 1 BOTTLE (0363-1323-02) |
| 0363-1323-03 | 00363132303 | 510 g in 1 BOTTLE (0363-1323-03) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0363-1323 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0363-1323 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0363-1323. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.